Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
COVID-19 convalescent plasma (2 trials)
Coronavirus Infections (Phase 2)
Infections (Phase 3)
Severe Acute Respiratory Syndrome (Phase 2)
Trials (2 total)
Trial APIs (1 total)